AVE 50.0% 0.3¢ avecho biotechnology limited

what's next for 2012???, page-24

  1. 1,912 Posts.
    lightbulb Created with Sketch. 214
    agreed TL -just stating the facts that there are few lose ends, and just like my 18 year old son who can be a little ambitious at times, so can our company in potentially overshooting the mark in their own ambitions. 2012 is the year to show credibility, crack heads, pull through and whatever other cliché you wanna stick with this ... I don't though - if TPM is as good as they say it is our partners will be making TPM a priority. We only need to look at the words Novartis dished out “we’re excited about the benefits it will bring”
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.959K 1.497M

Buyers (Bids)

No. Vol. Price($)
62 100922609 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20841900 7
View Market Depth
Last trade - 14.13pm 15/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.